aluates Reports

$ 0.0

Automative

NSAIDs Drug - Global Market Insights and Sales Trends 2024

Published Date: December 2023

Report Code: QYRE-Auto-0J3316

Global NSAIDs Drug Market Insights and Forecast to 2028

BUY CHAPTERS

NSAIDs Drug - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-0J3316

Report

December 2023

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

GSK

Grunenthal

Bayer

Sanofi

Eli Lilly

Astrazeneca plc

Endo

Merck

Depomed

Yunnan Baiyao

TEVA

J & J

Allergan plc

Purdue

NSAIDs Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

NSAIDs Drug - Market

The global NSAIDs Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NSAIDs Drug in various end use industries. The expanding demands from the Hospitals, Clinics and Drugstores,, are propelling NSAIDs Drug market. Ibuprofen, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Naproxen segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NSAIDs Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global NSAIDs Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global NSAIDs Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NSAIDs Drug sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of NSAIDs Drug covered in this report include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc.

The global NSAIDs Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Pfizer

GSK

Grunenthal

Bayer

Sanofi

Eli Lilly

AstraZeneca

Endo

Merck

Depomed

Yunnan Baiyao

Teva

J&J

Allergan

Purdue

Scope of NSAIDs Drug - Market Report

Report Metric	Details
Report Name	NSAIDs Drug - Market
CAGR	5%
Global NSAIDs Drug market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NSAIDs Drug market, Segment by Type:	Ibuprofen Naproxen
Global NSAIDs Drug market, by Application	Hospitals Clinics Drugstores
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NSAIDs Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the NSAIDs Drug - Market report?

Ans: The Applications covered in the NSAIDs Drug - Market report are Hospitals, Clinics, Drugstores

What are the Type segmentation covered in the NSAIDs Drug - Market report?

Ans: The Types covered in the NSAIDs Drug - Market report are Ibuprofen, Naproxen

1 Market Overview of NSAIDs Drug

1.1 NSAIDs Drug Market Overview

1.1.1 NSAIDs Drug Product Scope

1.1.2 NSAIDs Drug Market Status and Outlook

1.2 Global NSAIDs Drug Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global NSAIDs Drug Market Size by Region (2018-2029)

1.4 Global NSAIDs Drug Historic Market Size by Region (2018-2023)

1.5 Global NSAIDs Drug Market Size Forecast by Region (2024-2029)

1.6 Key Regions, NSAIDs Drug Market Size (2018-2029)

1.6.1 North America NSAIDs Drug Market Size (2018-2029)

1.6.2 Europe NSAIDs Drug Market Size (2018-2029)

1.6.3 Asia-Pacific NSAIDs Drug Market Size (2018-2029)

1.6.4 Latin America NSAIDs Drug Market Size (2018-2029)

1.6.5 Middle East & Africa NSAIDs Drug Market Size (2018-2029)

2 NSAIDs Drug Market by Type

2.1 Introduction

2.1.1 Ibuprofen

2.1.2 Naproxen

2.2 Global NSAIDs Drug Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global NSAIDs Drug Historic Market Size by Type (2018-2023)

2.2.2 Global NSAIDs Drug Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America NSAIDs Drug Revenue Breakdown by Type (2018-2029)

2.3.2 Europe NSAIDs Drug Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America NSAIDs Drug Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Type (2018-2029)

3 NSAIDs Drug Market Overview by Application

3.1 Introduction

3.1.1 Hospitals

3.1.2 Clinics

3.1.3 Drugstores

3.2 Global NSAIDs Drug Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global NSAIDs Drug Historic Market Size by Application (2018-2023)

3.2.2 Global NSAIDs Drug Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America NSAIDs Drug Revenue Breakdown by Application (2018-2029)

3.3.2 Europe NSAIDs Drug Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America NSAIDs Drug Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Application (2018-2029)

4 NSAIDs Drug Competition Analysis by Players

4.1 Global NSAIDs Drug Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2022)

4.3 Date of Key Players Enter into NSAIDs Drug Market

4.4 Global Top Players NSAIDs Drug Headquarters and Area Served

4.5 Key Players NSAIDs Drug Product Solution and Service

4.6 Competitive Status

4.6.1 NSAIDs Drug Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Pfizer

5.1.1 Pfizer Profile

5.1.2 Pfizer Main Business

5.1.3 Pfizer NSAIDs Drug Products, Services and Solutions

5.1.4 Pfizer NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.1.5 Pfizer Recent Developments

5.2 GSK

5.2.1 GSK Profile

5.2.2 GSK Main Business

5.2.3 GSK NSAIDs Drug Products, Services and Solutions

5.2.4 GSK NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.2.5 GSK Recent Developments

5.3 Grunenthal

5.3.1 Grunenthal Profile

5.3.2 Grunenthal Main Business

5.3.3 Grunenthal NSAIDs Drug Products, Services and Solutions

5.3.4 Grunenthal NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.3.5 Bayer Recent Developments

5.4 Bayer

5.4.1 Bayer Profile

5.4.2 Bayer Main Business

5.4.3 Bayer NSAIDs Drug Products, Services and Solutions

5.4.4 Bayer NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.4.5 Bayer Recent Developments

5.5 Sanofi

5.5.1 Sanofi Profile

5.5.2 Sanofi Main Business

5.5.3 Sanofi NSAIDs Drug Products, Services and Solutions

5.5.4 Sanofi NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.5.5 Sanofi Recent Developments

5.6 Eli Lilly

5.6.1 Eli Lilly Profile

5.6.2 Eli Lilly Main Business

5.6.3 Eli Lilly NSAIDs Drug Products, Services and Solutions

5.6.4 Eli Lilly NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.6.5 Eli Lilly Recent Developments

5.7 AstraZeneca

5.7.1 AstraZeneca Profile

5.7.2 AstraZeneca Main Business

5.7.3 AstraZeneca NSAIDs Drug Products, Services and Solutions

5.7.4 AstraZeneca NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.7.5 AstraZeneca Recent Developments

5.8 Endo

5.8.1 Endo Profile

5.8.2 Endo Main Business

5.8.3 Endo NSAIDs Drug Products, Services and Solutions

5.8.4 Endo NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.8.5 Endo Recent Developments

5.9 Merck

5.9.1 Merck Profile

5.9.2 Merck Main Business

5.9.3 Merck NSAIDs Drug Products, Services and Solutions

5.9.4 Merck NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.9.5 Merck Recent Developments

5.10 Depomed

5.10.1 Depomed Profile

5.10.2 Depomed Main Business

5.10.3 Depomed NSAIDs Drug Products, Services and Solutions

5.10.4 Depomed NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.10.5 Depomed Recent Developments

5.11 Yunnan Baiyao

5.11.1 Yunnan Baiyao Profile

5.11.2 Yunnan Baiyao Main Business

5.11.3 Yunnan Baiyao NSAIDs Drug Products, Services and Solutions

5.11.4 Yunnan Baiyao NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.11.5 Yunnan Baiyao Recent Developments

5.12 Teva

5.12.1 Teva Profile

5.12.2 Teva Main Business

5.12.3 Teva NSAIDs Drug Products, Services and Solutions

5.12.4 Teva NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.12.5 Teva Recent Developments

5.13 J&J

5.13.1 J&J Profile

5.13.2 J&J Main Business

5.13.3 J&J NSAIDs Drug Products, Services and Solutions

5.13.4 J&J NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.13.5 J&J Recent Developments

5.14 Allergan

5.14.1 Allergan Profile

5.14.2 Allergan Main Business

5.14.3 Allergan NSAIDs Drug Products, Services and Solutions

5.14.4 Allergan NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.14.5 Allergan Recent Developments

5.15 Purdue

5.15.1 Purdue Profile

5.15.2 Purdue Main Business

5.15.3 Purdue NSAIDs Drug Products, Services and Solutions

5.15.4 Purdue NSAIDs Drug Revenue (US$ Million) & (2018-2023)

5.15.5 Purdue Recent Developments

6 North America

6.1 North America NSAIDs Drug Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe NSAIDs Drug Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific NSAIDs Drug Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America NSAIDs Drug Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa NSAIDs Drug Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 NSAIDs Drug Market Dynamics

11.1 NSAIDs Drug Industry Trends

11.2 NSAIDs Drug Market Drivers

11.3 NSAIDs Drug Market Challenges

11.4 NSAIDs Drug Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Pfizer Inc

GSK

Grunenthal

Bayer

Sanofi

Eli Lilly

Astrazeneca plc

Endo

Merck

Depomed

Yunnan Baiyao

TEVA

J & J

Allergan plc

Purdue

List of Tables

Table 1. Global Market NSAIDs Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global NSAIDs Drug Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global NSAIDs Drug Market Size Share by Region (2018-2023)

Table 4. Global NSAIDs Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global NSAIDs Drug Forecasted Market Size Share by Region (2024-2029)

Table 6. Global NSAIDs Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global NSAIDs Drug Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global NSAIDs Drug Revenue Market Share by Type (2018-2023)

Table 9. Global NSAIDs Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global NSAIDs Drug Revenue Market Share by Type (2024-2029)

Table 11. North America NSAIDs Drug Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America NSAIDs Drug Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe NSAIDs Drug Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe NSAIDs Drug Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific NSAIDs Drug Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific NSAIDs Drug Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America NSAIDs Drug Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America NSAIDs Drug Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa NSAIDs Drug Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa NSAIDs Drug Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global NSAIDs Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global NSAIDs Drug Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global NSAIDs Drug Revenue Market Share by Application (2018-2023)

Table 24. Global NSAIDs Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global NSAIDs Drug Revenue Market Share by Application (2024-2029)

Table 26. North America NSAIDs Drug Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America NSAIDs Drug Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe NSAIDs Drug Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe NSAIDs Drug Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific NSAIDs Drug Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific NSAIDs Drug Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America NSAIDs Drug Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America NSAIDs Drug Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa NSAIDs Drug Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa NSAIDs Drug Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global NSAIDs Drug Revenue (US$ Million) by Players (2018-2023)

Table 37. Global NSAIDs Drug Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2022)

Table 39. Date of Key Players Enter into NSAIDs Drug Market

Table 40. Global NSAIDs Drug Key Players Headquarters and Area Served

Table 41. NSAIDs Drug Product Solution and Service

Table 42. Global NSAIDs Drug Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Pfizer Basic Information List

Table 45. Pfizer Description and Business Overview

Table 46. Pfizer NSAIDs Drug Products, Services and Solutions

Table 47. Revenue (US$ Million) in NSAIDs Drug Business of Pfizer (2018-2023)

Table 48. Pfizer Recent Developments

Table 49. GSK Basic Information List

Table 50. GSK Description and Business Overview

Table 51. GSK NSAIDs Drug Products, Services and Solutions

Table 52. Revenue (US$ Million) in NSAIDs Drug Business of GSK (2018-2023)

Table 53. GSK Recent Developments

Table 54. Grunenthal Basic Information List

Table 55. Grunenthal Description and Business Overview

Table 56. Grunenthal NSAIDs Drug Products, Services and Solutions

Table 57. Revenue (US$ Million) in NSAIDs Drug Business of Grunenthal (2018-2023)

Table 58. Grunenthal Recent Developments

Table 59. Bayer Basic Information List

Table 60. Bayer Description and Business Overview

Table 61. Bayer NSAIDs Drug Products, Services and Solutions

Table 62. Revenue (US$ Million) in NSAIDs Drug Business of Bayer (2018-2023)

Table 63. Bayer Recent Developments

Table 64. Sanofi Basic Information List

Table 65. Sanofi Description and Business Overview

Table 66. Sanofi NSAIDs Drug Products, Services and Solutions

Table 67. Revenue (US$ Million) in NSAIDs Drug Business of Sanofi (2018-2023)

Table 68. Sanofi Recent Developments

Table 69. Eli Lilly Basic Information List

Table 70. Eli Lilly Description and Business Overview

Table 71. Eli Lilly NSAIDs Drug Products, Services and Solutions

Table 72. Revenue (US$ Million) in NSAIDs Drug Business of Eli Lilly (2018-2023)

Table 73. Eli Lilly Recent Developments

Table 74. AstraZeneca Basic Information List

Table 75. AstraZeneca Description and Business Overview

Table 76. AstraZeneca NSAIDs Drug Products, Services and Solutions

Table 77. Revenue (US$ Million) in NSAIDs Drug Business of AstraZeneca (2018-2023)

Table 78. AstraZeneca Recent Developments

Table 79. Endo Basic Information List

Table 80. Endo Description and Business Overview

Table 81. Endo NSAIDs Drug Products, Services and Solutions

Table 82. Revenue (US$ Million) in NSAIDs Drug Business of Endo (2018-2023)

Table 83. Endo Recent Developments

Table 84. Merck Basic Information List

Table 85. Merck Description and Business Overview

Table 86. Merck NSAIDs Drug Products, Services and Solutions

Table 87. Revenue (US$ Million) in NSAIDs Drug Business of Merck (2018-2023)

Table 88. Merck Recent Developments

Table 89. Depomed Basic Information List

Table 90. Depomed Description and Business Overview

Table 91. Depomed NSAIDs Drug Products, Services and Solutions

Table 92. Revenue (US$ Million) in NSAIDs Drug Business of Depomed (2018-2023)

Table 93. Depomed Recent Developments

Table 94. Yunnan Baiyao Basic Information List

Table 95. Yunnan Baiyao Description and Business Overview

Table 96. Yunnan Baiyao NSAIDs Drug Products, Services and Solutions

Table 97. Revenue (US$ Million) in NSAIDs Drug Business of Yunnan Baiyao (2018-2023)

Table 98. Yunnan Baiyao Recent Developments

Table 99. Teva Basic Information List

Table 100. Teva Description and Business Overview

Table 101. Teva NSAIDs Drug Products, Services and Solutions

Table 102. Revenue (US$ Million) in NSAIDs Drug Business of Teva (2018-2023)

Table 103. Teva Recent Developments

Table 104. J&J Basic Information List

Table 105. J&J Description and Business Overview

Table 106. J&J NSAIDs Drug Products, Services and Solutions

Table 107. Revenue (US$ Million) in NSAIDs Drug Business of J&J (2018-2023)

Table 108. J&J Recent Developments

Table 109. Allergan Basic Information List

Table 110. Allergan Description and Business Overview

Table 111. Allergan NSAIDs Drug Products, Services and Solutions

Table 112. Revenue (US$ Million) in NSAIDs Drug Business of Allergan (2018-2023)

Table 113. Allergan Recent Developments

Table 114. Purdue Basic Information List

Table 115. Purdue Description and Business Overview

Table 116. Purdue NSAIDs Drug Products, Services and Solutions

Table 117. Revenue (US$ Million) in NSAIDs Drug Business of Purdue (2018-2023)

Table 118. Purdue Recent Developments

Table 119. North America NSAIDs Drug Market Size by Country (2018-2023) & (US$ Million)

Table 120. North America NSAIDs Drug Market Size by Country (2024-2029) & (US$ Million)

Table 121. Europe NSAIDs Drug Market Size by Country (2018-2023) & (US$ Million)

Table 122. Europe NSAIDs Drug Market Size by Country (2024-2029) & (US$ Million)

Table 123. Asia-Pacific NSAIDs Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 124. Asia-Pacific NSAIDs Drug Market Size by Region (2018-2023) & (US$ Million)

Table 125. Asia-Pacific NSAIDs Drug Market Size by Region (2024-2029) & (US$ Million)

Table 126. Asia-Pacific NSAIDs Drug Market Share by Region (2018-2023)

Table 127. Asia-Pacific NSAIDs Drug Market Share by Region (2024-2029)

Table 128. Latin America NSAIDs Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 129. Latin America NSAIDs Drug Market Size by Country (2018-2023) & (US$ Million)

Table 130. Latin America NSAIDs Drug Market Size by Country (2024-2029) & (US$ Million)

Table 131. Middle East & Africa NSAIDs Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 132. Middle East & Africa NSAIDs Drug Market Size by Country (2018-2023) & (US$ Million)

Table 133. Middle East & Africa NSAIDs Drug Market Size by Country (2024-2029) & (US$ Million)

Table 134. NSAIDs Drug Market Trends

Table 135. NSAIDs Drug Market Drivers

Table 136. NSAIDs Drug Market Challenges

Table 137. NSAIDs Drug Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NSAIDs Drug Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global NSAIDs Drug Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global NSAIDs Drug Market Share by Regions: 2022 VS 2029

Figure 4. Global NSAIDs Drug Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America NSAIDs Drug Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe NSAIDs Drug Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific NSAIDs Drug Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America NSAIDs Drug Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa NSAIDs Drug Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Ibuprofen

Figure 11. Global Ibuprofen Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Naproxen

Figure 13. Global Naproxen Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Global NSAIDs Drug Market Size Share by Type: 2022 & 2029

Figure 15. North America NSAIDs Drug Revenue Market Share by Type (2018-2029)

Figure 16. Europe NSAIDs Drug Revenue Market Share by Type (2018-2029)

Figure 17. Asia-Pacific NSAIDs Drug Revenue Market Share by Type (2018-2029)

Figure 18. Latin America NSAIDs Drug Revenue Market Share by Type (2018-2029)

Figure 19. Middle East and Africa NSAIDs Drug Revenue Market Share by Type (2018-2029)

Figure 20. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 21. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Drugstores Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Global NSAIDs Drug Market Size Share by Application: 2022 & 2029

Figure 24. North America NSAIDs Drug Revenue Market Share by Application (2018-2029)

Figure 25. Europe NSAIDs Drug Revenue Market Share by Application (2018-2029)

Figure 26. Asia-Pacific NSAIDs Drug Revenue Market Share by Application (2018-2029)

Figure 27. Latin America NSAIDs Drug Revenue Market Share by Application (2018-2029)

Figure 28. Middle East and Africa NSAIDs Drug Revenue Market Share by Application (2018-2029)

Figure 29. NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 30. Global Top 5 and Top 10 Players NSAIDs Drug Market Share in 2022

Figure 31. North America NSAIDs Drug Market Share by Country (2018-2029)

Figure 32. U.S. NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 33. Canada NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 34. Germany NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 35. France NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 36. U.K. NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 37. Italy NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 38. Russia NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 39. Nordic Countries NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 40. Asia-Pacific NSAIDs Drug Market Share by Region (2018-2029)

Figure 41. China NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 42. Japan NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 43. South Korea NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 44. Southeast Asia NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 45. India NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 46. Australia NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 47. Latin America NSAIDs Drug Market Share by Country (2018-2029)

Figure 48. Mexico NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 49. Brazil NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 50. Middle East & Africa NSAIDs Drug Market Share by Country (2018-2029)

Figure 51. Turkey NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 52. Saudi Arabia NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 53. UAE NSAIDs Drug Market Size (2018-2029) & (US$ Million)

Figure 54. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions